SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001013594-24-000194
Filing Date
2024-02-14
Accepted
2024-02-14 16:18:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 marinus13ga4-02142024.htm SC 13G/A 163933
  Complete submission text file 0001013594-24-000194.txt   165690
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Subject) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88269 | Film No.: 24638607
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 250 WEST 55TH STREET 33RD FLOOR NEW YORK NY 10019
Business Address 250 WEST 55TH STREET 33RD FLOOR NEW YORK NY 10019 212-356-6200
Lion Point Capital, LP (Filed by) CIK: 0001643354 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1230
Type: SC 13G/A